Matthew Ducar
Overview
Explore the profile of Matthew Ducar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
1981
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stover E, Oh C, Keskula P, Choudhury A, Tseng Y, Adalsteinsson V, et al.
Prostate
. 2022 Jan;
82(5):584-597.
PMID: 35084050
Background: Primary and metastatic prostate cancers have low mutation rates and recurrent alterations in a small set of genes, enabling targeted sequencing of prostate cancer-associated genes as an efficient approach...
2.
Kundra R, Zhang H, Sheridan R, Sirintrapun S, Wang A, Ochoa A, et al.
JCO Clin Cancer Inform
. 2021 Feb;
5:221-230.
PMID: 33625877
Purpose: Cancer classification is foundational for patient care and oncology research. Systems such as International Classification of Diseases for Oncology (ICD-O), Systematized Nomenclature of Medicine Clinical Terms (SNOMED-CT), and National...
3.
Dunn I, Du Z, Touat M, Sisti M, Wen P, Umeton R, et al.
JCO Precis Oncol
. 2019 Feb;
2018.
PMID: 30801050
No abstract available.
4.
Burns M, Liao Z, Yamagata N, Pouliot G, Stevenson K, Neuberg D, et al.
Leukemia
. 2018 Apr;
32(10):2126-2137.
PMID: 29654263
The role of Hedgehog signaling in normal and malignant T-cell development is controversial. Recently, Hedgehog pathway mutations have been described in T-ALL, but whether mutational activation of Hedgehog signaling drives...
5.
Stachler M, Camarda N, Deitrick C, Kim A, Agoston A, Odze R, et al.
Gastroenterology
. 2018 Apr;
155(1):156-167.
PMID: 29608884
Background & Aims: Barrett's esophagus (BE) is the greatest risk factor for esophageal adenocarcinoma (EAC), but only a small proportion of patients with BE develop cancer. Biomarkers might be able...
6.
Melchardt T, Magnes T, Hufnagl C, Thorner A, Ducar M, Neureiter D, et al.
Eur J Cancer
. 2018 Feb;
93:69-78.
PMID: 29477794
Background: Tumour heterogeneity and clonal evolution within a cancer patient are deemed responsible for relapse in malignancies and present challenges to the principles of targeted therapy, for which treatment modality...
7.
Teot L, Schneider M, Thorner A, Tian J, Chi Y, Ducar M, et al.
Cancer
. 2018 Feb;
124(9):1973-1981.
PMID: 29461635
Background: Pediatric paired box 3:forkhead box protein O1 fusion-negative (PF-) rhabdomyosarcoma (RMS) represents a diverse spectrum of tumors with marked differences in histology, myogenic differentiation, and clinical behavior. Methods: This...
8.
Busch E, Hornick J, Umeton R, Albayrak A, Lindeman N, Macconaill L, et al.
Oncotarget
. 2017 Nov;
8(49):85680-85691.
PMID: 29156750
Metastases are involved in most cancer deaths. Evidence has suggested that cancer cell detachment from primary tumors might occur largely via the mechanism of epithelial-mesenchymal transition (EMT) activated by epigenetic...
9.
Qian Z, Rubinson D, Nowak J, Morales-Oyarvide V, Dunne R, Kozak M, et al.
JAMA Oncol
. 2017 Nov;
4(3):e173420.
PMID: 29098284
Importance: Although patients with resected pancreatic adenocarcinoma are at high risk for disease recurrence, few biomarkers are available to inform patient outcomes. Objective: To evaluate the alterations of the 4...
10.
Bi W, Greenwald N, Abedalthagafi M, Wala J, Gibson W, Agarwalla P, et al.
NPJ Genom Med
. 2017 Jul;
2.
PMID: 28713588
High-grade meningiomas frequently recur and are associated with high rates of morbidity and mortality. To determine the factors that promote the development and evolution of these tumors, we analyzed the...